With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

The glove box market is propelled by increasing demand across industries such as pharmaceuticals, healthcare, semiconductors, and nuclear research, where controlled environments are essential. Rising ...

Iovance has a huge opportunity with its tumor-infiltrating lymphocyte (TIL) therapies. However, there are several drawbacks to investing in the stock right now. Even if Iovance isn't a ...

The firm has set its sights on broadening the network of deep science startups while also deepening its investment pipeline.

The sector is defensive, and biopharmaceuticals have, for the most part, limited tariff and transfer price exposure, he ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

The market turbulence unleashed by President Donald Trump’s tariff policies will likely evaporate the trickle of biotech IPOs ...

Find out what makes Basel's biotech hub so successful, as it has cemented its place as one of Europe's brightest life ...

Political pressure and persistently high interest rates have some wondering if the industry’s model is broken.